Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

662 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy.
Hanna GG, Murray L, Patel R, Jain S, Aitken KL, Franks KN, van As N, Tree A, Hatfield P, Harrow S, McDonald F, Ahmed M, Saran FH, Webster GJ, Khoo V, Landau D, Eaton DJ, Hawkins MA. Hanna GG, et al. Among authors: landau d. Clin Oncol (R Coll Radiol). 2018 Jan;30(1):5-14. doi: 10.1016/j.clon.2017.09.007. Epub 2017 Oct 13. Clin Oncol (R Coll Radiol). 2018. PMID: 29033164 Free article.
Stereotactic body radiotherapy for oligometastatic disease.
Hanna GG, Landau D. Hanna GG, et al. Among authors: landau d. Clin Oncol (R Coll Radiol). 2015 May;27(5):290-7. doi: 10.1016/j.clon.2015.02.003. Epub 2015 Mar 12. Clin Oncol (R Coll Radiol). 2015. PMID: 25770653 Review.
Re: Stereotactic Body Radiotherapy for Oligometastatic Disease.
Hanna GG, Landau D. Hanna GG, et al. Among authors: landau d. Clin Oncol (R Coll Radiol). 2015 Sep;27(9):543-4. doi: 10.1016/j.clon.2015.06.011. Epub 2015 Jul 2. Clin Oncol (R Coll Radiol). 2015. PMID: 26144320 No abstract available.
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.
Conibear J, Chia B, Ngai Y, Bates AT, Counsell N, Patel R, Eaton D, Faivre-Finn C, Fenwick J, Forster M, Hanna GG, Harden S, Mayles P, Moinuddin S, Landau D. Conibear J, et al. Among authors: landau d. BMJ Open. 2018 Apr 17;8(4):e020690. doi: 10.1136/bmjopen-2017-020690. BMJ Open. 2018. PMID: 29666135 Free PMC article.
The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer.
Vivekanandan S, Landau DB, Counsell N, Warren DR, Khwanda A, Rosen SD, Parsons E, Ngai Y, Farrelly L, Hughes L, Hawkins MA, Fenwick JD. Vivekanandan S, et al. Among authors: landau db. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):51-60. doi: 10.1016/j.ijrobp.2017.04.026. Epub 2017 Apr 27. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816160 Free PMC article.
Quantitative Analysis of Radiation-Associated Parenchymal Lung Change.
Chandy E, Szmul A, Stavropoulou A, Jacob J, Veiga C, Landau D, Wilson J, Gulliford S, Fenwick JD, Hawkins MA, Hiley C, McClelland JR. Chandy E, et al. Among authors: landau d. Cancers (Basel). 2022 Feb 14;14(4):946. doi: 10.3390/cancers14040946. Cancers (Basel). 2022. PMID: 35205693 Free PMC article.
662 results